Sneezing, itching, swelling, coughing, millions of people around the world face these symptoms daily due to allergies. From seasonal hay fever to life-threatening anaphylaxis, allergies impact lives in countless ways. But as science advances, so do our methods for diagnosing and treating allergic conditions. The global allergy diagnostics and treatments market is growing rapidly, driven by rising allergy cases, awareness, and technological progress.
Allergies are no longer considered minor health issues. They affect quality of life and productivity and, in severe cases, pose serious health risks. As the demand for accurate diagnosis and effective therapies increases, the global market is evolving to meet the challenge.
According to market research, the global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.3% from 2025 through 2030.
The global allergy diagnostics and treatments market has grown steadily over the past decade. Factors such as urbanization, changing lifestyles, climate change, and pollution are contributing to the rising prevalence of allergies, especially in developing countries. Conditions like asthma, allergic rhinitis, eczema, and food allergies are now more commonly diagnosed than ever before.
This increased burden has led to a surge in demand for advanced diagnostic tools and innovative treatment options, creating opportunities for biotech firms, pharmaceutical companies, and diagnostics developers globally.
Several key trends are fueling the growth of this market:
Studies estimate that up to 30–40% of the world’s population now suffers from some form of allergy. Air pollution, changing dietary habits, and extended exposure to allergens are significant contributors, particularly in urban settings.
Traditional methods like skin prick testing and blood-based IgE testing are being enhanced with molecular diagnostics, component-resolved diagnostics (CRD), and point-of-care allergy tests. These innovations allow faster, more accurate, and personalized diagnosis, improving treatment outcomes.
Public health campaigns, rising patient education, and easier access to specialists have led to earlier detection and management of allergies, especially in children, where early intervention can prevent chronic symptoms.
The allergy treatment landscape is broadening from antihistamines and corticosteroids to immunotherapy and biologics. Subcutaneous and sublingual immunotherapy (SCIT and SLIT) offer long-term relief, while biologic drugs like omalizumab are transforming the management of severe asthma and chronic hives.